Antares Pharma, Inc. (ATRS)

Revenue

$183.46M

TTM · Period ending: · USD

ATRS logo

ATRS Revenue

Latest reported$183.46M
ATRS TTM Revenue ($3.39M → $183.46M)
High-resolution chart · PNG

ATRS revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Antares Pharma, Inc. Revenue — Trailing twelve months (TTM) (USD)
Period endingRevenue (USD)
3,991,804
3,391,804
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.